Scarica l'app Stockscreener
1.48
10.84%
-0.18
Pre-mercato:
1.51
0.03
+2.03%
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
Harvard Bioscience Inc (HBIO) Stock Sees a-10.84 Decrease - The News Heater
OceanFirst Financial Corp (OCFC) vs. Its Peers: A Comparison - The News Heater
JPMorgan Chase & Co. Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.7 amid market challenges - Investing.com India
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in January - MarketBeat
Assenagon Asset Management S.A. Sells 132,516 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges - Investing.com Canada
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges By Investing.com - Investing.com South Africa
Microelectrode Array In Vitro Market to Reach US$ 25.67 Million by 2031, Driven by Neuroscience and Animal Testing Alternatives - GlobeNewswire Inc.
Barclays PLC Has $157,000 Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Acquired by Barclays PLC - Defense World
bioMérieux Gains FDA Clearance for Tropical Fever Test - MSN
One Harvard Bioscience Insider Raised Their Stake In The Previous Year - Yahoo Finance
Harvard Bioscience (NASDAQ:HBIO) Stock Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Jane Street Group LLC Sells 37,349 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding - dallasinnovates.com
LeddarTech Reports on Participation in CES 2025 - The Manila Times
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference - The Manila Times
Harvard Bioscience CEO to Present at Sidoti Micro Cap Conference on January 22 - StockTitan
Further weakness as Harvard Bioscience (NASDAQ:HBIO) drops 11% this week, taking three-year losses to 69% - Simply Wall St
HBIO stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa
HBIO stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
Harvard Bioscience, Inc. (NASDAQ:HBIO) Position Boosted by Barclays PLC - Defense World
Geode Capital Management LLC Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria
HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance
BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World
Lexaria Bioscience Taps Harvard Medical Expert to Accelerate GLP-1 & Hypertension Drug Development - StockTitan
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World
Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com
Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
Harvard Bioscience files $100M mixed securities shelf - MSN
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
Prepacked Chromatography Columns Market Size Is Expected To - GlobeNewswire
272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
10.10%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):